Journal of Medicinal Chemistry
Volume 40, Issue 4 (February 14, 1997)
Copyright © 1997
American Chemical Society
391-394 | Neuritogenic Effect of Epolactaene Derivatives on Human Neuroblastoma Cells Which Lack High-Affinity Nerve Growth Factor Receptors
|
395-407 | Novel Naphthalene Derivatives as Inhibitors of Human Immunoglobulin E Antibody Production
|
408-412 | Cytokinin-Derived Cyclin-Dependent Kinase Inhibitors: Synthesis and cdc2 Inhibitory Activity of Olomoucine and Related Compounds
 ek, |
413-426 | Tyrosine Kinase Inhibitors. 6. Structure-Activity Relationships among N- and 3-Substituted 2,2'-Diselenobis(1H-indoles) for Inhibition of Protein Tyrosine Kinases and Comparative in Vitro and in Vivo Studies against Selected Sulfur Congeners
|
427-436 | Antiulcer Agents. 6. Analysis of the in Vitro Biochemical and in Vivo Gastric Antisecretory Activity of Substituted Imidazo[1,2-a]pyridines and Related Analogues Using Comparative Molecular Field Analysis and Hypothetical Active Site Lattice Methodologies
|
437-448 | Synthesis, Antimalarial Activity, and Molecular Modeling of Tebuquine Analogues
|
449-454 | Chromophore-Modified Bis-Naphthalimides: Synthesis and Antitumor Activity of Bis-Dibenz[de,h]isoquinoline-1,3-diones
|
455-462 | Studies on Selectin Blockers. 4. Structure-Function Relationships of Sulfated Sialyl Lewis X Hexasaccharide Ceramides toward E-, P-, and L-Selectin Binding
|
463-469 | Water Soluble Furoxan Derivatives as NO Prodrugs
|
470-478 | Synthesis and Dihydrofolate Reductase Inhibitory Activities of 2,4-Diamino-5-deaza and 2,4-Diamino-5,10-dideaza Lipophilic Antifolates
|
479-485 | Synthesis and Biological Evaluation of Nonclassical 2,4-Diamino-5-methylpyrido[2,3-d]pyrimidines with Novel Side Chain Substituents as Potential Inhibitors of Dihydrofolate Reductases
|
486-494 | Novel 3'-C/N-Substituted 2',3'- -D-Dideoxynucleosides as Potential Chemotherapeutic Agents. 1. Thymidine Derivatives: Synthesis, Structure, and Broad Spectrum Antiviral Properties
|
495-505 | Ortho-Substituted Benzofused Macrocyclic Lactams as Zinc Metalloprotease Inhibitors
|
506-514 | Meta-Substituted Benzofused Macrocyclic Lactams as Zinc Metalloprotease Inhibitors
|
515-519 | Cytotoxicity of Platinum(II) Dinuclear Complexes with 1-Alkylthymine Ligands against Mouse Sarcoma 180 Cells
|
520-527 | AMPA Receptor Agonists: Synthesis, Protolytic Properties, and Pharmacology of 3-Isothiazolol Bioisosteres of Glutamic Acid
 lund,
|
528-537 | Design, Synthesis, and Pharmacological Characterization of (+)-2-Aminobicyclo[3.1.0]hexane-2,6-dicarboxylic Acid (LY354740): A Potent, Selective, and Orally Active Group 2 Metabotropic Glutamate Receptor Agonist Possessing Anticonvulsant and Anxiolytic Properties
|
538-546 | Muscarinic Analgesics with Potent and Selective Effects on the Gastrointestinal Tract: Potential Application for the Treatment of Irritable Bowel Syndrome
|
547-558 | Synthesis and Structure-Activity Relationship of a New Series of Potent AT1 Selective Angiotensin II Receptor Antagonists: 5-(Biphenyl-4-ylmethyl)pyrazoles
|
559-573 | 5-Aminocoumarans: Dual Inhibitors of Lipid Peroxidation and Dopamine Release with Protective Effects against Central Nervous System Trauma and Ischemia
|
574-585 | [[(Arylpiperazinyl)alkyl]thio]thieno[2,3-d]pyrimidinone Derivatives as High-Affinity, Selective 5-HT1A Receptor Ligands
|
586-593 | New 2-Piperazinylbenzimidazole Derivatives as 5-HT3 Antagonists. Synthesis and Pharmacological Evaluation
|
594-601 | Conformational Analysis of Three NK1 Tripeptide Antagonists: A Proton Nuclear Magnetic Resonance Study
|
602-607 | Effects of log P and Phenyl Ring Conformation on the Binding of 5-Phenylhydantoins to the Voltage-Dependent Sodium Channel
|
608-621 | New Esters of 4-Amino-5-chloro-2-methoxybenzoic Acid as Potent Agonists and Antagonists for 5-HT4 Receptors
|
622-624 | (+)-7-Deaza-5'-noraristeromycin as an Anti-Trypanosomal Agent
|
625-629 | Synthesis and Anti-Trypanosomal Activity of Various 8-Aza-7-deaza-5'-noraristeromycin Derivatives
|
630-630 | Bioorganic Chemistry: Nucleic Acids Edited by Sidney M. Hecht. Oxford University Press, New York. 1996. viii + 500 pp. 17 × 24 cm. ISBN 0-19-508467-5. $59.95.
|
630-631 | Regulatory Protein Modification. Techniques and Protocols. Neuromethods. 30 Edited by Hugh C. Hemmings, Jr. The Humana Press, Totowa, NJ. 1997. xiv + 445 pp. 16 × 23.5 cm. ISBN 0-89603-415-1. $75.00.
|
631-631 | Bioconjugate Techniques By Greg T. Hermanson. Academic Press, San Diego, CA. 1996. xxiii + 785 pp. 18 × 26 cm. ISBN 0-12-342335-X. $99.00. $49.95 (pbk).
|
631-631 | Annual Reports in Medicinal Chemistry. Volume 31 Editor-in-Chief: James A. Bristol. Academic Press, Inc., A Division of Harcourt Brace & Co., San Diego, CA. 1996. xi + 413 pp. 17 × 25 cm. ISBN 0-12-040531-8. $70.00 (pbk).
|
632-632 |
|